Process for the preparation of 5-fluoro-5-deoxy and 5-epi-fluoro-5-deoxy-4,6-di-O-(aminoglycosyl)-1,3-diaminocyclitols and novel 5-fluoro-5-deoxy and 5-epi-fluoro-5-deoxy derivatives produced thereby
AssigneeSchering Corporation
InventorsPeter J. L. Daniels, Dinanath Rane
Life of this patent
Estimating the term…
Abstract
A novel process whereby 4,6-di-O-(aminoglycosyl)-1,3-diaminocyclitols are reacted with a dialkylaminosulfur trifluoride to produce novel 5-fluoro-5-deoxy and 5-epi-fluoro-5-deoxy-4,6-di-O-(aminoglycosyl)-1,3-diaminocyclitol antibacterial agents.
Claims10
The process of preparing 5-fluoro-5-deoxy or 5-epi-fluoro-5-deoxy derivatives of 4,6-di-O-(aminoglycosyl)-1,3-diaminocyclitols or their l-N-X derivatives, wherein X is 13 CH.sub.2 Y or ##STR5## wherein Y is a member selected from the group consisting of hydrogen, alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl, aminohydroxyalkyl and alkylaminohyroxyalkyl, said Y having up to 4 carbon atoms and when substituted by both amino and hydroxy groups, said groups are on different carbon atoms;
- which comprises the reaction of dialkylaminosulfur trifluoride with a 4,6-di-O-(aminoglycosyl)-1,3-diaminocyclitol or its l-N-X derivative, having all of its amino and hydroxyl functions other than the 5-epi-hydroxyl or 5-hydroxyl function protected, in an inert organic solvent in the temperature range of from about -100.degree. C. to about -50.degree. C., followed by removal of the amino and hydroxyl protecting groups from the so-produced 5-fluoro-5-deoxy or 5-epi-fluoro-5-deoxy-N-protected-O-protected-4,6-di-O-(aminoglycosyl)-1,3- diaminocyclitol, or its l-N-X derivative.
A 5-fluoro-5-deoxy or 5-epi-fluoro-5-deoxy derivative of a 4,6-di-O-(aminoglycosyl)-1,3-diaminocyclitol wherein said 4,6-di-O-(aminoglycosyl)-1,3-diaminocyclitol is selected from the group consisting of gentamicin A, gentamicin B, gentamicin B.sub.1, gentamicin C.sub.2a, gentamicin C.sub.2b, gentamicin X.sub.2, verdamicin, tobramycin, Antibiotic G-418, Antibiotic 66-40B, Antibiotic 66-40D, Antibiotic JI-20A, Antibiotic JI-20B, Antibiotic G-52, kanamycin A, kanamycin B and 3',4'-dideoxykanamycin B;
- and the l-N-X derivatives thereof, wherein X is --CH.sub.2 Y or ##STR6## wherein Y is a member selected from the group consisting of hydrogen, alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl, aminohydroxyalkyl and alkylaminohydroxyalkyl, said Y having up to4 carbon atoms and when substituted by both amino and hydroxy groups, said groups are on different carbon atoms;
- and the pharmaceutically acceptable acid addition salt thereof.
Dependencies are inferred from the claim text.